mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 4,213,071 | 0 | A | C | 65.0% | 6.5 / 17.6 | 20 | G162G (GGT→GGG) | iclR | glyoxylate bypass operon transcriptional repressor IclR |
| * | NZ_CP009273 | 4,213,077 | 0 | A | C | 63.2% | 12.9 / 15.1 | 19 | G160G (GGT→GGG) | iclR | glyoxylate bypass operon transcriptional repressor IclR |
| * | NZ_CP009273 | 431,972 | 0 | C | A | 60.0% | ‑2.5 / 10.1 | 10 | Q295K (CAA→AAA) | thiL | thiamine‑phosphate kinase |
| * | NZ_CP009273 | 228,175 | 0 | A | G | 58.8% | 6.2 / 14.0 | 17 | G189G (GGA→GGG) | yafD | endonuclease/exonuclease/phosphatase family protein |
| * | NZ_CP009273 | 228,191 | 0 | A | G | 58.8% | 5.4 / 15.5 | 17 | S195G (AGC→GGC) | yafD | endonuclease/exonuclease/phosphatase family protein |
| * | NZ_CP009273 | 4,102,506 | 0 | T | G | 58.3% | 5.5 / 11.4 | 12 | G88G (GGT→GGG) | yiiR | DUF805 domain‑containing protein |
| * | NZ_CP009273 | 2,669,465 | 0 | C | A | 55.6% | 3.7 / 10.7 | 9 | L240F (TTG→TTT) | yphD | ABC transporter permease |
| * | NZ_CP009273 | 3,713,220 | 0 | A | C | 55.0% | 19.5 / 24.4 | 20 | intergenic (+92/‑189) | yiaG/cspA | HTH‑type transcriptional regulator/RNA chaperone/antiterminator CspA |
| * | NZ_CP009273 | 341,039 | 0 | C | A | 54.5% | 2.9 / 14.5 | 11 | intergenic (+337/‑76) | BW25113_RS01680/BW25113_RS01685 | hypothetical protein/hypothetical protein |
| * | NZ_CP009273 | 899,438 | 0 | A | C | 54.5% | 8.9 / 10.5 | 11 | G162G (GGT→GGG) | ybjP | lipoprotein |
| * | NZ_CP009273 | 1,571,380 | 0 | A | C | 54.5% | 6.2 / 12.7 | 11 | V166G (GTA→GGA) | yddB | TonB‑dependent receptor plug domain‑containing protein |
| * | NZ_CP009273 | 4,558,329 | 0 | C | A | 54.5% | 9.6 / 29.7 | 22 | R3L (CGT→CTT) | mdtM | multidrug efflux MFS transporter MdtM |
| * | NZ_CP009273 | 3,055,679 | 0 | A | C | 53.8% | 7.9 / 13.9 | 13 | T491P (ACC→CCC) | scpA | methylmalonyl‑CoA mutase |
| * | NZ_CP009273 | 4,411,039 | 0 | A | T | 53.3% | 4.3 / 15.4 | 16 | I415F (ATT→TTT) | ulaA | PTS ascorbate transporter subunit IIC |
| * | NZ_CP009273 | 3,549,559 | 0 | G | A | 44.0% | 18.1 / 11.5 | 25 | S217F (TCC→TTC) | rtcA | RNA 3'‑terminal phosphate cyclase |
| * | NZ_CP009273 | 4,417,765 | 0 | A | G | 36.4% | 21.2 / 17.4 | 22 | pseudogene (255/402 nt) | BW25113_RS21850 | TetR/AcrR family transcriptional regulator |
| * | NZ_CP009273 | 576,566 | 0 | C | T | 35.7% | 7.9 / 10.4 | 14 | Q93* (CAG→TAG) | nohD | DNA‑packaging protein |
| * | NZ_CP009273 | 3,919,208 | 0 | T | G | 34.8% | 19.0 / 25.5 | 23 | intergenic (‑215/+164) | mnmG/mioC | tRNA uridine‑5‑carboxymethylaminomethyl(34) synthesis enzyme MnmG/FMN‑binding protein MioC |